BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Dr. Assad Al-Ammar Joins Irvine Pharmaceutical Services, Inc. as the New Minerals Analysis Manager in Response to the Growing Needs for USP Elemental Impurities Testing


6/15/2011 6:43:35 AM

IRVINE, Calif., June 15, 2011 /PRNewswire/ -- Irvine Pharmaceutical Services is pleased to announce the exciting addition of Dr. Assad Al-Ammar to Irvine's analytical management team as the new Manager of Minerals. Dr. Al-Ammar brings with him over 25 years of analytical experience. Dr. Al-Ammar has over fourteen years of experience with ICP-MS and has fifteen peer-reviewed research papers published in both the United States and Europe. Additionally, Dr. Al-Ammar has seven years experience with LC-ICP-MS and GC-ICP-MS speciation of toxic and pharmaceutically important elements and fifteen years of experience with ICP-AES, XRF, GC, and LC.

"With the upcoming changes to USP Chapter 231, Heavy Metals, Dr. Al-Ammar is a terrific addition to our minerals group," said Yvonne Verburgt, Vice President of Business Development and Marketing. "We believe his extensive expertise and experience with ICP/ICP-MS methodology will even further strengthen the department's level of scientific leadership and serve as a tremendous asset to our clients with the upcoming proposed new USP General Chapters, Elemental Impurities 232 and 233."

Dr. Al-Ammar holds a Ph.D. in Analytical Chemistry from Glasgow University, United Kingdom, and was a postdoctoral fellow at the University of Massachusetts.

Learn more about Irvine and the upcoming proposed USP General Chapters, Elemental Impurities 232 and 233 at www.irvinepharma.com or call us today at 877-445-6654.

About Irvine Pharmaceutical Services, Inc.

Irvine Pharmaceutical Services, Inc., along with its affiliate Avrio Biopharmaceuticals, is a premier contract pharmaceutical development and manufacturing organization providing support to the pharmaceutical, biopharmaceutical, and medical device industries. Irvine and Avrio together provide full cGMP specialized product development services such as, preformulation / formulation development, analytical method development, aseptic fill and finish, stability testing and complete analytical CMC testing. Learn more at www.irvinepharma.com or call 877-445-6554.

SOURCE Irvine Pharmaceutical Services, Inc.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES